benralizumab

Spain

Drugs containing this active substance

  • FASENRA 30 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN

    It is used in adults to treat severe eosinophilic asthma (when standard medications do not control it well) and eosinophilic granulomatosis with polyangiitis (EGPA).

    Form: solution for injection in pre-filled pen

    Active substance Dosage
    benralizumab 30 mg

    ATC: R03D R03DX R03DX10

    Manufacturer: Astrazeneca Ab

  • FASENRA 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

    It is used in adults to treat severe eosinophilic asthma (when symptoms are not controlled with other medications) and Eosinophilic Granulomatosis with Polyangiitis (EGPA).

    Form: solution for injection in a pre-filled syringe

    Active substance Dosage
    benralizumab 30 mg

    ATC: R03D R03DX R03DX10

    Manufacturer: Astrazeneca Ab